SQI DIAGNOSTICS INC SQD

SQD TSXV
SQD
SQI DIAGNOSTICS INC TSXV
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Health Services
Industry: Medical/Nursing Services
SQI Diagnostics, Inc. is a life sciences company that develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics. The firm is focused on developing the business units targeting organ transplant, autoimmune disease, and serological testing. It involves in commercializing its developmental COVID-19 antibody test kit, and also the RALI-Dx and RALI-fast Point-of-Care tests to triage COVID-19 patients for respiratory distress. The company was founded by Peter Lea in 1999 and is headquartered in Toronto, Canada.